Sanara MedTech
SMTI
31 hedge funds and large institutions have $17.4M invested in Sanara MedTech in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
75% more capital invested
Capital invested by funds: $9.94M → $17.4M (+$7.43M)
11% more funds holding
Funds holding: 28 → 31 (+3)
0.57% more ownership
Funds ownership: 4.03% → 4.6% (+0.57%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$525K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$477K |
| 3 |
BAMCO Inc
New York
|
+$339K |
| 4 |
Citigroup
New York
|
+$286K |
| 5 |
Millennium Management
New York
|
+$276K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$438K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$350K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$166K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$83.6K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$79K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ARS
26
Adirondack Retirement Specialists
Queensbury,
New York
| $25.8K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $23K | +$5.27K | +153 | +43% |
|
|
LF
28
Lee Financial
Dallas,
Texas
| $22.8K | – | – | – |
|
29
UBS Group
Zurich,
Switzerland
| $11.6K | +$1.9K | +55 | +28% |
|
30
Osaic Holdings
Scottsdale,
Arizona
| $6K | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $956 | +$34 | +1 | +5% |
|
|
32
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$438K | -14,768 | Closed |
|
|
LCM
33
Laurion Capital Management
New York
| – | -$350K | -11,805 | Closed |
|
34
Lazard Asset Management
New York
| – | -$22K | -748 | Closed |
|
SMTI Hedge Fund Activity: Q4 2022 in Review
31 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2022, worth a combined $17.4M — up 75% from $9.94M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SMTI positions and 4 closed out — a net gain of 3 holders — while 10 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $525K. The largest seller was CAPTRUST Financial Advisors, exiting entirely with an estimated $438K sold.
- 31 institutional investors held Sanara MedTech (SMTI) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $17.4M of Sanara MedTech stock for Q4 2022, up 75% quarter-over-quarter.
- 7 funds opened new Sanara MedTech positions in Q4 2022 and 4 closed out, a net change of +3 holders.
- The largest Sanara MedTech buyer in Q4 2022 was Susquehanna International Group, an estimated $525K added.
- The largest Sanara MedTech seller in Q4 2022 was CAPTRUST Financial Advisors, an estimated $438K sold.
Based on aggregated 13F filings for Q4 2022.